Xenobiotic Metabolism and Detoxification
On this page
Direct answer
Biotransformation converts lipid-soluble xenobiotics — drugs, pesticides, pollutants — into water-soluble products the kidney and bile can excrete, mainly in the liver's smooth endoplasmic reticulum. Phase I chemistry (oxidation by the cytochrome P450 system, plus reductions and hydrolyses) installs or exposes a functional group; phase II conjugation (glucuronidation, sulphation, acetylation, methylation, glycine and glutathione conjugation) masks it with a hydrophilic handle. The same machinery sometimes activates procarcinogens and poisons, and paracetamol overdose — NAPQI formation exhausting glutathione — is the exam's textbook demonstration.
What you must remember
- Cytochrome P450 is a haem-thiolate mono-oxygenase family of roughly 57 human genes; CYP3A4 metabolises the largest share of clinical drugs (in the order of a third or more).
- Pharmacogenetic classics: CYP2D6 poor metabolisers get no analgesia from codeine (cannot form morphine), while ultrarapid metabolisers (gene amplification) risk toxicity; CYP2C9 and VKORC1 variants guide warfarin dosing.
- Phase II reactions with their donors: glucuronidation (UDPGA, most common — bilirubin, morphine, steroids), sulphation (PAPS), acetylation (acetyl-CoA, via NAT2 fast/slow acetylator polymorphism), methylation (SAM), glycine conjugation (benzoate to hippurate) and glutathione conjugation (mercapturic acid pathway).
- Slow acetylators: isoniazid peripheral neuropathy and drug-induced lupus with hydralazine and procainamide; fast acetylators need higher isoniazid doses and are prone to hepatotoxicity from rapid acetylhydrazine formation — the classic Indian tuberculosis-therapy viva.
- Paracetamol: about 5 per cent is converted by CYP2E1 (also 1A2, 3A4) to NAPQI, detoxified by glutathione; overdose (roughly 150 mg/kg) depletes glutathione, NAPQI adducts hepatocyte proteins, and centrilobular necrosis follows — N-acetylcysteine replenishes glutathione and is the antidote, most effective within 8–10 hours.
- Enzyme induction (rifampicin, phenytoin, carbamazepine, chronic alcohol, St John's wort) causes therapeutic failure through accelerated clearance; inhibition (ketoconazole, ciprofloxacin, cimetidine, grapefruit juice inactivating intestinal CYP3A4) causes toxicity.
- Procarcinogen activation: benzo[a]pyrene in smoke and aflatoxin B1 from Aspergillus-contaminated groundnuts and maize are converted by P450 to epoxides; aflatoxin's signature is the TP53 codon 249 mutation in hepatocellular carcinoma, relevant to Indian food storage.
- Alcohol metabolism: alcohol dehydrogenase (zero-order kinetics), the induced microsomal ethanol oxidising system (CYP2E1) and catalase; excess NADH drives fatty liver, hypoglycaemia and lactic acidosis; disulfiram blocks aldehyde dehydrogenase.
- Phase III elimination: ATP-dependent transport such as P-glycoprotein (MDR1) pumping conjugates and drugs into bile and urine — the basis of multidrug resistance in cancer chemotherapy.
Reasoning through two overdoses and one interaction
First, a young woman ingests 30 paracetamol tablets and presents after 14 hours. The Rumack–Matthew nomogram plots her four-hour-post-ingestion-equivalent level above the treatment line; whatever the delay, N-acetylcysteine is started because it repletes glutathione and directly detoxifies NAPQI. Second, a patient on stable warfarin is given co-trimoxazole for a urinary infection; three days later the INR is 7 — sulphamethoxazole inhibited CYP2C9, warfarin clearance fell, and the anticoagulant effect surged. The general rule: check every new prescription against the CYP profile of the drugs the patient already takes. Third, a man on rifampicin for tuberculosis starts oral contraceptive pills and conceives — rifampicin induced CYP3A4, accelerating oestrogen breakdown. Induction loses drugs; inhibition accumulates them; and the same P450 that detoxifies can, with aflatoxin on the plate, activate a carcinogen that mutates p53.
Where students slip
Students assume biotransformation equals detoxification; phase I frequently creates reactive intermediates — paracetamol to NAPQI, aflatoxin to epoxide — so the honest phrase is "biotransformation to more polar, usually less active products". Second, conjugation reactions sound interchangeable but are not all detoxifying: acetylation of isoniazid itself produces the hepatotoxic acetylhydrazine. Third, they forget glucuronidation of bilirubin is the same UGT system that handles many drugs — Gilbert syndrome patients conjugate some drugs sluggishly too. And zero-order kinetics trips candidates: ethanol saturates its dehydrogenase, so a constant amount (not fraction) is metabolised per hour — the reason blood alcohol does not fall faster when you drink more.
Frequently asked questions
What are phase I and phase II reactions of xenobiotic metabolism?
Phase I inserts or unmasks functional groups — chiefly cytochrome P450 oxidations, plus reductions and hydrolyses; phase II conjugates the product with glucuronic acid, sulphate, acetate, methyl, glycine or glutathione, rendering it water-soluble for excretion.
Why is N-acetylcysteine the antidote for paracetamol poisoning?
Overdose floods the CYP2E1 pathway with NAPQI, which consumes hepatic glutathione and then adducts cellular proteins; N-acetylcysteine replenishes glutathione stores and itself binds NAPQI, preventing centrilobular hepatic necrosis when given early.
What is the clinical impact of CYP induction and inhibition?
Inducers (rifampicin, phenytoin, alcohol) accelerate clearance and cause therapeutic failure of co-administered drugs such as oral contraceptives and warfarin; inhibitors (ketoconazole, ciprofloxacin, grapefruit juice) reduce clearance and cause toxicity.
What determines fast and slow acetylator status and its consequences?
NAT2 gene polymorphism in the acetylation pathway: slow acetylators accumulate isoniazid (peripheral neuropathy, drug-induced lupus with hydralazine), while fast acetylators clear it quickly but form more hepatotoxic metabolite.
How does aflatoxin B1 cause hepatocellular carcinoma?
Liver P450 converts it to a reactive epoxide that binds DNA, producing a signature G-to-T mutation at codon 249 of TP53; chronic dietary exposure from fungal-contaminated groundnuts and maize synergises with hepatitis B in hepatocarcinogenesis.